Schwitalla et al. [28] demonstrated that p53 suppressed the inflammatory microenvironment associated with NF-κB activation in the advanced stage of disease, and that the loss of the p53 gene and related NF-κB pathway activation ultimately induced EMT in tumor cells, which might be a necessary event to regulate colon tumor progression. This evidence concerns the gene TP53 and neoplasm.